Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: Initial experience with intracoronary tenecteplase

医学 蒂米 经皮冠状动脉介入治疗 传统PCI 心脏病学 内科学 心肌梗塞 特奈特普酶 阿昔单抗 氯吡格雷 心源性休克 外科 溶栓
作者
Robert V. Kelly,Eron D. Crouch,Heather Krumnacher,Mauricio G. Cohen,George A. Stouffer
出处
期刊:Catheterization and Cardiovascular Interventions [Wiley]
卷期号:66 (3): 327-332 被引量:55
标识
DOI:10.1002/ccd.20521
摘要

Intracoronary thrombus is associated with increased risk of in-laboratory vessel closure, recurrent myocardial infarction (MI), urgent vessel revascularization, and death. There is a lack of consensus on what represents the ideal treatment for patients with thrombotic complications during percutaneous coronary intervention (PCI), but the development of newer thrombolytic agents with increased fibrin specificity and longer half-life provides a potentially useful treatment option. In this study, the safety and efficacy of intracoronary tenecteplase (TNK) was evaluated in 34 patients (22 with acute ST elevation MI, 4 with rescue PCI, 6 with non-ST elevation MI, and 2 during elective PCI) who developed no-reflow, distal embolization, or visible intracoronary thrombus during PCI. The mean age was 57 years, 76% were Caucasian, and there were 14 women and 20 men. Cardiogenic shock was present in seven (21%) patients at baseline. All patients were being treated with aspirin and either unfractionated heparin (33 patients) or bivalrudin. Glycoprotein IIb/IIIa inhibitors were used in 76% of patients. Intracoronary TNK was used at a mean dose of 10.2 +/- 5.2 mg (median, 10 mg; range, 5-25 mg). There was one TIMI major bleeding event and three TIMI minor bleeding events. The mean hematocrit measured the morning following PCI was 35.5% +/- 4.9% in patients receiving TNK and 36.5% +/- 4.4% in a randomly selected sample of 150 consecutive patients undergoing PCI (P = 0.25). In conjunction with mechanical intervention, TNK was successful at dissolving angiographic thrombus and/or improving flow in 91% of patients. In conclusion, intracoronary TNK is safe and well tolerated in patients who develop thrombotic complications during complex PCI.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
lee发布了新的文献求助10
1秒前
Ee完成签到,获得积分10
1秒前
2秒前
微笑发布了新的文献求助10
2秒前
last_champion完成签到,获得积分10
2秒前
酷波er的应助被文献达人采纳,获得10
2秒前
2秒前
顺问冬安发布了新的文献求助10
2秒前
XFF发布了新的文献求助10
3秒前
3秒前
浅梦完成签到,获得积分10
3秒前
诚心的凡雁完成签到,获得积分10
3秒前
万能图书馆的应助被可妍昇采纳,获得10
4秒前
玉簪发布了新的文献求助10
4秒前
正直凌文完成签到,获得积分10
4秒前
4秒前
4秒前
4秒前
4秒前
5秒前
成功发布了新的文献求助10
5秒前
zhangmemng完成签到,获得积分10
5秒前
6秒前
6秒前
Borky发布了新的文献求助10
7秒前
脑洞疼的应助被微笑采纳,获得10
7秒前
QQ的应助被朱雀采纳,获得10
7秒前
wanci的应助被漫山采纳,获得10
7秒前
珍珠发布了新的文献求助30
7秒前
神勇的元芹完成签到,获得积分10
8秒前
lee完成签到,获得积分10
8秒前
ZJ发布了新的文献求助10
8秒前
通通完成签到,获得积分10
8秒前
发nature的研究生大人完成签到,获得积分10
8秒前
8秒前
善良咖啡发布了新的文献求助10
8秒前
8秒前
hua发布了新的文献求助10
9秒前
安详凡柔完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180757
求助须知:如何正确求助?哪些是违规求助? 9570857
关于积分的说明 21814590
捐赠科研通 7777053
什么是DOI,文献DOI怎么找? 3433314
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479315